QMS Medical Allied Services Ltd Management Discussions

Healthcare has become one of Indias largest sectors, both in terms of revenue and employment. Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance and medical equipment. The Indian healthcare sector is growing at a brisk pace due to its strengthening coverage, services, and increasing expenditure by public as well as private players.

Indias healthcare delivery system is categorised into two major components - public and private. The government, i.e., the public healthcare system, comprises limited secondary and tertiary care institutions in key cities and focuses on providing basic healthcare facilities in the form of Primary Healthcare Centers (PHCs) in rural areas. The private sector provides most secondary, tertiary, and quaternary care institutions with a major concentration in metros, tier- I, and tier-II cities.

Indias competitive advantage lies in its large pool of well-trained medical professionals. India is also cost-competitive compared to its peers in Asia and Western countries. The cost of surgery in India is about one-tenth of that in the US or Western Europe. The low cost of medical services has resulted in a rise in the countrys medical tourism, attracting patients from across the world. Moreover, India has emerged as a hub for R&D activities for international players due to its relatively low cost of clinical research.

QMS MAS sees massive opportunities on the horizon in terms of expanding our current offerings across our current and new institutional clients. Our online and retail market is also on the rise with our online division growing. Our own brand Q Devices which specializes in consumer healthcare products, has shown a great growth trajectory and is continuing to grow in the current fiscal year. Having Mr. Kapil Dev as our brand ambassador has certainly improved our chances of becoming a dominant player in this competitive yet lucrative space.

The Indian healthcare industry is currently on the rise as there is significant investment from both the private and public space, with a specific interest in preventative healthcare as well as patient support solutions. QMS MAS stands ready with its wide range of offerings and highly trained and capable national workforce to attend to the requirements of our institutional clients in both the pharmaceutical and insurance domains.

The requirements for high quality diagnostic medical devices is also growing significantly amongst both medical practitioners as well as patients. QMS MAS with its extensive experience in validating, sourcing, importing & distribution of the same is perfectly placed to cater to these requirements and fulfil them with the highest quality of service and product.

Opportunities are rife for QMS MAS with a possibility of expansion into the hospital segment for product distribution as well as executing service projects with various state governments in the public domain. We will also look to be the first to acquire prime and innovative medical technologies that will supplement all our revenue lines including our product distribution, screening services and point of care distributions.

FY 24-25 saw the rise of the service segment in QMS MAS as our clients began to reap the benefits of our patient screening programs as well as the patient support programs. Our flagship patient service program known as HUMRAHI, which was launched by Lupin LTD but completely managed by QMS MAS, has shown remarkable growth with over 40,000 downloads and users utilising the support services of our educators and our nutritionists with aplomb. The profitability of the service division far surpasses that of our other divisions.

Our product distribution channel has accounted for the majority of our revenue and we continue to associate ourselves with the best brands in the healthcare industry and provide pristine products of great repute.

Our services division have conducted over 25,000 screening camps across the country and have screened and diagnosed over 2 Lakh patients, immensely contributing to reduce treatment costs and early interventions for a variety of Non Communicable Diseases.

Our Point Of Care Division with our exclusive machines and renewables has made its mark with our institutional client base and customers and continues to be an important part of our growth journey.

QMS MAS is perfectly positioned to expand its business operations on a national scale. The healthcare is constantly growing due to influx of funds into healthcare infrastructure development as well as other delivery systems. This influx requires tertiary services to flourish such as high class medical technology as well as the requisite screening services, for which we stand ready.

The risk factor that constantly looms over the healthcare industry in general is a change in government policy that may happen due to socio-economic or socio-political issues.

Price-caps, increase in red-tape and regulatory overhauls will affect sale and profitability. Increase on import duties for medical devices also tends to create a challenging environment to operate in.

The Companys internal control system is structured to ensure there is prevention of loss, no unlawful use and no disposal of its assets. There are stringent processes in place that are functioning with rigid oversight by management. The management is constantly informed of all transactions, all of which are authorised as per the relevant processes. The Company maintains its books of accounts and reports financial statements in accordance with all applicable accounting standards. The Company has hired internal auditors to examine several aspects of the Companys operations. Management and the Boards Audit Committee periodically evaluate the audit reports. Consequent to implementation of Companies Act, 2013 (Act), the Company has complied with the specific requirements in terms of Section 134(5)(e) of the Act calling for establishment and implementation of an Internal Financial Control framework that supports compliance with requirements of the Act in relation to the Directors responsibility statement.

The Financial performance of the Company for the Financial Year 2024-25 is described in details in the Directors Report under the head financial summary / performance of the company

The summary of Consolidated financial highlights for the financial year ended March 31, 2025 and the previous financial year ended March 31, 2024 is given below *

The Company did not have any Subsidiary, Associate, or Joint Venture Company as on March 31, 2024. The information presented herein is provided solely for comparative purposes